1). Bataille R., Harousseau J. Multiple myeloma. New Engl J Med. 1997. 336:1657–64.
Article
2). Safa AM., Van Ordstrand HS. Pleural effusion due to multiple myeloma. Chest. 1973. 64:246–8.
Article
3). Hwang HK., Lee CK., Lee KH., Hyun MS., Shim BS., Lee HW. A case of multiple myeloma with pleural effusion. Korean J Hematol. 1992. 27:161–5.
4). Kintzer JS., Rosenow EC., Kyle RA. Thoracic and pulmonary abnormalities in multiple myeloma. Arch Intern Med. 1978. 138:727–30.
Article
5). Hata H., Matsuzaki H., Tanaka K, et al. Ectopic production of salivary-type amylase by a IgA-lambda-type multiple myeloma. Cancer. 1988. 62:1511–5.
6). Kwan WC., Lam SC., Klimo P. Kappa light-chain myeloma with pleural involvement. Chest. 1984. 86:494–6.
Article
7). Kamal MK., Williams E., Poskitt TR. IgD myeloma with malignant pleural effusion. South Med J. 1987. 80:657–8.
Article
8). Rodriguez JN., Pereira A., Martinez JC., Conde J., Pujol E. Pleural effusion in multiple myeloma. Chest. 1994. 105:622–4.
Article
9). Kim YM., Lee KK., Oh HS, et al. Myelomatous effusion with poor response to chemotherapy. J Korean Med Sci. 2000. 15:243–6.
Article
10). Hughes JC., Votaw ML. Pleural effusion in multiple myeloma. Cancer. 1979. 44:1150–4.
Article
11). Sasser RL., Yam LT., Li CY. Myeloma with involvement of the serous cavities. Cytologic and immuno-chemical diagnosis and literature review. Acta Cytol. 1990. 34:479–85.
12). Kamble R., Wilson CS., Fassas A, et al. Malignant pleural effusion of multiple myeloma: prognostic factors and outcome. Leuk Lymphoma. 2005. 46:1137–42.
Article
13). McMillen JJ., Krueger SK., Dyer GA. Leukocytoclastic vasculitis in association with immunoglobulin A myeloma. Ann Intern Med. 1986. 105:709–10.
Article
14). Bayer-Garner IB., Smoller BR. Leukocytoclastic (small vessel) vasculitis in multiple myeloma. Clin Exp Dermatol. 2003. 28:521–4.
Article